Royalty Pharma PLC (RPRX)
32.20
+0.17
(+0.53%)
USD |
NASDAQ |
Apr 25, 16:00
32.18
-0.02
(-0.06%)
After-Hours: 20:00
Royalty Pharma Enterprise Value: 23.19B for April 25, 2025
View 4,000+ Financial Data Types:
Add
Browse
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Humana Inc | 23.25B |
| Biogen Inc | 21.32B |
| Ionis Pharmaceuticals Inc | 3.678B |
| Arvinas Inc | -416.41M |
| Biohaven Ltd | 1.539B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 208.21M |
| Revenue (Quarterly) | 593.64M |
| Total Expenses (Quarterly) | 232.13M |
| EPS Diluted (Quarterly) | 0.3531 |
| Profit Margin (Quarterly) | 35.07% |
| Earnings Yield | 5.60% |
| Operating Earnings Yield | 6.76% |
| Normalized Earnings Yield | 4.616 |